Predilife: Strong Growth in Sales of Predictive Assessments in 2024

Predilife has announced a significant increase in its sales in 2024. Specializing in predictive health assessments, the company has doubled its sales volume compared to 2023, reaching 720,000 euros. This represents an increase of 106%.

Multi-pathology assessments have seen strong growth, increasing from 70 to 1,200 in 2024. This development reflects a growing interest among companies in the well-being of their employees. Nearly 80% of employees want to benefit from these assessments free of charge.

Predilife collaborates with various sectors, such as insurance and digital, and relies on partnerships with brokers and insurers to strengthen its distribution. Envisaging a sustainable integration of balance sheets into HR strategies, Predilife anticipates similar growth in 2025.